provided an in-depth analysis of 465 cases of triple-negative breast cancer (TNBC) by genomic and transcriptomic sequencing, and classified TNBC into four subtypes: luminal androgen receptor (LAR), immunomodulatory (IM), basal-like immune- suppressed (BLIS) and mesenchymal-like (MES). This evidence concerns the gene AR and triple-negative breast carcinoma.